According to a new market report published by Lucintel, the future of the biobanking market looks promising with opportunities in regenerative medicine, life science research, and clinical research applications. The global biobanking market is expected to grow with a CAGR of 5% from 2020 to 2025. The major drivers for this market are increasing research activities related to genomic, rising demand for cost-effective drug discovery and development, and favorable government initiatives to support regenerative medicine research.
To download report brochure, please go to https://www.lucintel.com/biobanking-market.aspx and click "download brochure" tab from the menu
Biobanking refers to the process through which samples of bodily fluid or tissue are collected for medical research to improve understanding of health and diseases of humans. In this market, equipment, consumables, service, and software are the major products and services. Lucintel forecasts that equipment will remain the largest product and service segment over the forecast period due to an increasing number of biosamples to be stored and growing number of biobanks.
Within this market, regenerative medicine will remain the largest application segment over the forecast period due to increasing research activities related to regenerative medicine and rising demand for well characterized and quality biosamples for research.
North America will remain the largest region over the forecast period due to increasing research and development expenditure and developed healthcare infrastructure in the region.
Askion, CTI Biotech, Cureline, Excilone, Firalis, Hamilton, LabVantage Solutions, LGC, PrecisionMed, and ProMedDx are among the major suppliers in the global biobanking market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global biobanking market by product and service, sample type, storage type, biobank type, ownership, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Biobanking Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global biobanking market by product and service, sample type, storage type, biobank type, ownership, application, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Equipment
Consumables
Services
Software
By Sample Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Blood Products
Human Tissue
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Manual Storage
Automated Storage
By Biobank Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Population Based Biobanks
Disease-Oriented Biobanks
By Ownership [Value ($ Million) shipment analysis for 2014 – 2025]:
National/Regional Agencies
Nonprofit Organizations
Universities
Private Organizations
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Regenerative Medicine
Life Science Research
Clinical Research
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.